Rafferty Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 14,847 shares of PCRX stock, worth $246,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,847

Previous 7,424 99.99%

Holding current value

$246,460

Previous $212,000 5.19%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $86,849 - $211,258	7,423 Added 99.99%	14,847 $223,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $189,312 - $233,930	7,424 New	7,424 $212,000
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $163,631 - $213,305	6,217 New	6,217 $209,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $7,890 - $9,069	154 Added 3.62%	4,404 $234,000
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $257 - $408	5 Added 0.12%	4,250 $248,000
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $192,636 - $245,456	-3,209 Reduced 43.05%	4,245 $324,000
Q4 2021 Feb 10, 2022	BUY	$47.97 - $62.21 $14,966 - $19,409	312 Added 4.37%	7,454 $449,000
Q3 2021 Nov 10, 2021	BUY	$54.64 - $61.3 $94,800 - $106,355	1,735 Added 32.09%	7,142 $400,000
Q2 2021 Aug 10, 2021	BUY	$59.18 - $69.99 $51,309 - $60,681	867 Added 19.1%	5,407 $328,000
Q1 2021 May 10, 2021	SELL	$59.31 - $78.82 $107,469 - $142,821	-1,812 Reduced 28.53%	4,540 $318,000
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $57,182 - $75,072	1,133 Added 21.71%	6,352 $380,000
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $33,364 - $40,446	642 Added 14.03%	5,219 $314,000
Q2 2020 Aug 07, 2020	BUY	$30.8 - $52.47 $140,971 - $240,155	4,577 New	4,577 $240,000
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $139,387 - $248,835	-4,908 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$36.31 - $46.83 $137,760 - $177,673	-3,794 Reduced 43.6%	4,908 $222,000
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $105,232 - $132,765	2,951 Added 51.31%	8,702 $331,000
Q2 2019 Aug 09, 2019	BUY	$36.57 - $47.97 $210,314 - $275,875	5,751 New	5,751 $250,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History